Compare Global X Robotics and Artificial Intelligence ETF (BOTZ) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X Robotics and Artificial Intelligence ETF vs Medtronic PLC — how do they compare? Global X Robotics and Artificial Intelligence ETF trades at $37.82, while Medtronic PLC trades at $90.74 (market cap $116.07B). The key difference: Medtronic PLC pays a 3.18% dividend while Global X Robotics and Artificial Intelligence ETF pays none. Which is the better fit depends on your goals.
| BOTZ | MDT | |
|---|---|---|
52-Week High | $41.63 | $105.35 |
52-Week Low | $31.99 | $73.75 |
Market Cap | — | $116.07B |
Sector | — | Health |
Enterprise Value | — | $134.82B |
Dividend Yield | — | 3.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BOTZ trades at $37.85, up 1.15% today, with a bullish technical signal from moving averages. The ETF's RSI levels suggest overbought conditions, while ADX indicates a strong trend. Recent news highlights its role in robotics and AI investing, with a focus on global tech exposure beyond U.S. markets.
Outlook remains positive due to thematic growth in robotics and AI, supported by institutional interest. Risks include sector volatility and competition from other ETFs. The dividend of $0.02 scheduled for July 2026 adds income appeal, but valuation metrics are unavailable for deeper analysis.
Medtronic (MDT) trades at $89.99, up 0.65% with strong technical momentum and bullish moving average signals. The company demonstrates solid fundamentals with consistent earnings beats, 13.2% net income margin, and positive cash flow trends. Recent product innovations including the Hugo robotic surgery platform and AI surgical tools position MDT for growth. Analyst consensus remains strongly positive with 60% buy ratings and $98.75 price target.
MDT presents a compelling investment case with steady revenue growth, dividend aristocrat status, and technological leadership in medical devices. Key risks include increasing debt levels and competitive pressures from Intuitive Surgical. The stock's current valuation at 24.31 P/E appears reasonable given growth prospects, with upside potential to consensus targets if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Global X Robotics and Artificial Intelligence ETF
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that are involved in the development of robotics and/or artificial intelligence. The fund is non-diversified.
Read more on BOTZ →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
